Effect of inflammation on kidney function and pharmacokinetics of COX-2 selective nonsteroidal anti-inflammatory drugs rofecoxib and meloxicam-Reference-Cited by-同舟云学术

Effect of inflammation on kidney function and pharmacokinetics of COX-2 selective nonsteroidal anti-inflammatory drugs rofecoxib and meloxicam

Published:2008-10 Issue:7 Volume:28 Page:829-838
ISSN:0260-437X
Container-title:Journal of Applied Toxicology
language:en
Short-container-title:J. Appl. Toxicol.

Author:

Harirforoosh Sam,Jamali Fakhreddin

Publisher

Wiley

Subject

Toxicology

Reference45 articles.

1. Pharmacokinetic study of meloxicam in the rat;Aghazadeh-Habashi;Proceedings of the Canadian Society for Pharmaceutical Sciences 6th Annual Symposium

2. Cytokines and cytokine inhibitors or antagonists in rheumatoid arthritis;Arend;Arthritis Rheum.,1990

3. Subclinical renal dysfunction in rheumatoid arthritis;Boers;Arthritis Rheum.,1990

4. Cyclooxygenase 2 and the kidney;Breyer;Curr. Opin. Nephrol. Hypertens.,2001

5. The effect of cholestyramine on the pharmacokinetics of meloxicam, a new non-steroidal anti-inflammatory drug (NSAID), in man;Busch;Eur. J. Clin. Pharmac.,1995

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Hyperactive neutrophils infiltrate vital organs of tumor bearing host and contribute to gradual systemic deterioration via upregulated NE, MPO and MMP-9 activity;Immunology Letters;2022-01

2. Sitagliptin and tofacitinib ameliorate adjuvant induced arthritis via modulating the cross talk between JAK/STAT and TLR-4/NF-κB signaling pathways;Life Sciences;2020-11

3. Myrcene Attenuates Renal Inflammation and Oxidative Stress in the Adrenalectomized Rat Model;Molecules;2020-09-30

4. Reduced Heart Exposure of Diclofenac by Its Polymeric Micellar Formulation Normalizes CYP-Mediated Metabolism of Arachidonic Acid Imbalance in An Adjuvant Arthritis Rat Model: Implications in Reduced Cardiovascular Side Effects of Diclofenac by Nanodrug Delivery;Molecular Pharmaceutics;2020-02-05

5. Summary of a workshop on preclinical and translational safety assessment of CD3 bispecifics;Journal of Immunotoxicology;2020-01-01